Skip to Content
Merck
  • Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity.

Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity.

Gut (2014-05-30)
Claude Botha, Adam D Farmer, Matias Nilsson, Christina Brock, Ana D Gavrila, Asbjørn Mohr Drewes, Charles H Knowles, Qasim Aziz
ABSTRACT

Autonomic nervous system dysfunction has been implicated in visceral hypersensitivity. However, the specific contribution of the parasympathetic nervous system (PNS) is unclear. We aimed to determine whether physiological and pharmacological manipulation of parasympathetic tone influences the development of hypersensitivity in a validated model of acid-induced oesophageal pain. Prior to, and following, a 30-min distal oesophageal infusion of 0.15 M hydrochloric acid, pain thresholds to electrical stimulation were determined in the proximal non-acid exposed oesophagus in healthy subjects. Validated sympathetic (skin conductance response) and parasympathetic (cardiac vagal tone) parameters were measured at baseline and continuously thereafter. In study 1, 55 subjects were randomised in a pragmatic blinded crossover design to receive deep breathing or un-paced breathing during acid infusion. In study 2, 32 subjects were randomised in a blinded, crossover design to receive intravenous atropine or placebo (saline) with deep breathing during acid infusion. Study 1: Deep breathing increased cardiac vagal tone (2.1±2.3 vs -0.3±2.3, p=0.0006) with concomitant withdrawal of skin conductance response (-0.6±4.9 vs 3±4.8, p=0.03) in comparison with un-paced breathing. Deep breathing prevented the development of acid-induced oesophageal hypersensitivity in comparison with sham breathing (p=0.0001). Study 2: Atropine, in comparison with placebo, blocked the attenuating effect of deep breathing on the development of acid-induced oesophageal hypersensitivity (p=0.046). The development of oesophageal hyperalgesia is prevented by physiologically increasing parasympathetic tone. This effect is pharmacologically blocked with atropine, providing evidence that the PNS influences the development of oesophageal pain hypersensitivity.

MATERIALS
Product Number
Brand
Product Description

Atropine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Atropine sulfate salt monohydrate, ≥97% (TLC), crystalline
Atropine sulfate, European Pharmacopoeia (EP) Reference Standard
Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard
USP
Atropine sulfate, United States Pharmacopeia (USP) Reference Standard
Supelco
Atropine Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material